BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12927949)

  • 1. Outcome of antibiotic therapy for third-generation cephalosporin-resistant Gram-negative bacteraemia: an analysis of 249 cases caused by Citrobacter, Enterobacter and Serratia species.
    Kim BN; Lee SO; Choi SH; Kim NJ; Woo JH; Ryu J; Kim YS
    Int J Antimicrob Agents; 2003 Aug; 22(2):106-11. PubMed ID: 12927949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
    Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
    J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inducible amp C beta-lactamase producing gram-negative bacilli from blood stream infections: frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE).
    Pfaller MA; Jones RN; Marshall SA; Coffman SL; Hollis RJ; Edmond MB; Wenzel RP
    Diagn Microbiol Infect Dis; 1997 Aug; 28(4):211-9. PubMed ID: 9327251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of antimicrobial therapy on mortality in 377 episodes of Enterobacter spp. bacteraemia.
    Marcos M; Iñurrieta A; Soriano A; Martínez JA; Almela M; Marco F; Mensa J
    J Antimicrob Chemother; 2008 Aug; 62(2):397-403. PubMed ID: 18420813
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and diversity of qnr alleles in AmpC-producing Enterobacter cloacae, Enterobacter aerogenes, Citrobacter freundii and Serratia marcescens: a multicentre study from Korea.
    Park YJ; Yu JK; Lee S; Oh EJ; Woo GJ
    J Antimicrob Chemother; 2007 Oct; 60(4):868-71. PubMed ID: 17660263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serratia bacteremia in a large university hospital: trends in antibiotic resistance during 10 years and implications for antibiotic use.
    Choi SH; Kim YS; Chung JW; Kim TH; Choo EJ; Kim MN; Kim BN; Kim NJ; Woo JH; Ryu J
    Infect Control Hosp Epidemiol; 2002 Dec; 23(12):740-7. PubMed ID: 12517017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bloodstream infections caused by Enterobacter species: predictors of 30-day mortality rate and impact of broad-spectrum cephalosporin resistance on outcome.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Oh MD; Kim EC; Choe KW
    Clin Infect Dis; 2004 Sep; 39(6):812-8. PubMed ID: 15472813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Importance of Reviewing Antibiotic Courses by 48 Hours: Risk Factors for Third-Generation Cephalosporin Resistance Among AmpC Harboring Organisms in Urine and Respiratory Cultures.
    Stultz JS; Bice T; Johnstone K; Stuart CM; Shelton CM; Arnold SR; Bagga B; Lee KR
    Pediatr Infect Dis J; 2021 May; 40(5):440-445. PubMed ID: 33264210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
    Deal EN; Micek ST; Ritchie DJ; Reichley RM; Dunne WM; Kollef MH
    Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gram-negative bacillary meningitis in adult post-neurosurgical patients.
    Lu CH; Chang WN; Chuang YC; Chang HW
    Surg Neurol; 1999 Nov; 52(5):438-43; discussion 443-4. PubMed ID: 10595761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changing pattern of neonatal bacteremia. Microbiology and antibiotic resistance.
    Ellabib MS; Ordonez A; Ramali A; Walli A; Benayad T; Shebrlo H
    Saudi Med J; 2004 Dec; 25(12):1951-6. PubMed ID: 15711674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors and treatment outcomes of bloodstream infection caused by extended-spectrum cephalosporin-resistant Enterobacter species in adults with cancer.
    Huh K; Kang CI; Kim J; Cho SY; Ha YE; Joo EJ; Chung DR; Lee NY; Peck KR; Song JH
    Diagn Microbiol Infect Dis; 2014 Feb; 78(2):172-7. PubMed ID: 24321352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrobacter bacteremia in a tertiary care hospital.
    Gupta N; Yadav A; Choudhary U; Arora DR
    Scand J Infect Dis; 2003; 35(10):765-8. PubMed ID: 14606621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology and molecular characterization of extended-spectrum beta-lactamase-producing Enterobacter spp., Pantoea agglomerans, and Serratia marcescens isolates from a Bulgarian hospital.
    Markovska RD; Stoeva TJ; Bojkova KD; Mitov IG
    Microb Drug Resist; 2014 Apr; 20(2):131-7. PubMed ID: 24171449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment outcomes in patients with third-generation cephalosporin-resistant Enterobacter bacteremia.
    O'Neal CS; O'Neal HR; Daniels TL; Talbot TR
    Scand J Infect Dis; 2012 Oct; 44(10):726-32. PubMed ID: 22681412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y; Li JB; Ye DQ; Jiang ZJ
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.
    Harris PN; Wei JY; Shen AW; Abdile AA; Paynter S; Huxley RR; Pandeya N; Doi Y; Huh K; O'Neal CS; Talbot TR; Paterson DL
    J Antimicrob Chemother; 2016 Feb; 71(2):296-306. PubMed ID: 26542304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bacteraemia due to multidrug-resistant Gram-negative bacilli in cancer patients: risk factors, antibiotic therapy and outcomes.
    Gudiol C; Tubau F; Calatayud L; Garcia-Vidal C; Cisnal M; Sánchez-Ortega I; Duarte R; Calvo M; Carratalà J
    J Antimicrob Chemother; 2011 Mar; 66(3):657-63. PubMed ID: 21193475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical epidemiology of ciprofloxacin resistance and its relationship to broad-spectrum cephalosporin resistance in bloodstream infections caused by Enterobacter species.
    Kang CI; Kim SH; Park WB; Lee KD; Kim HB; Kim EC; Oh MD; Choe KW
    Infect Control Hosp Epidemiol; 2005 Jan; 26(1):88-92. PubMed ID: 15693414
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.